Soft-tissue Sarcoma
📧 Sign up to get email alerts when something new happens for Soft-tissue Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma [Phase 2]
This is a Phase 2 clinical trial update evaluating metformin hydrochloride in combination with standard systemic therapy for previously untr…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Pegylated Liposomal Doxorubicin (PLD) Versus Active Surveillance for Advanced Soft Tissue Sarcoma Patients Who Had Controlled Disease After Standard Anthracycline-based Treatment (MELODY) [Phase 2]
Phase 2 MELODY trial evaluating pegylated liposomal doxorubicin versus active surveillance in adults with advanced soft tissue sarcoma who h…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical trial evaluating cabozantinib in combination with temozolomide for unresectable or metastatic leiomyosarcoma and other soft…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcomas and Other Solid Tumor [Phase 1, Phase 2]
Multicohort Phase 1/2 clinical trial evaluating PM14 as monotherapy and in combination with radiotherapy for soft tissue sarcoma and other s…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas [Phase 1, Phase 2]
Phase I/II clinical trial update evaluating LB-100 in combination with doxorubicin versus doxorubicin alone as first-line treatment for adva…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial update evaluating the triple combo of trabectedin, ipilimumab, and nivolumab in previously treated advanced or me…